/PRNewswire/ The "Global mRNA Vaccines and Therapeutics Market: Focus on Application, mRNA Type, Country Data (13 Countries), and Competitive Landscape -.
WTO must revisit TRIPS to do away with patents on COVID vaccines as well as drugs
India is among several WTO members to demand patent waiver for vaccines, as have human rights bodies and global advocacy groups. However, there is strong lobbying by powerful pharmaceutical firms
The world needs more than COVID vaccine patent waivers
Engagement: 0
If the primary purpose of the World Trade Organization is âto open trade for the benefit of all,â it may be time for WTO to revisit its agreement on trade-related aspects of intellectual property rights (TRIPS) to do away with patents on COVID vaccines as well as drugs to hopefully save millions of lives across the world.
To embed, copy and paste the code into your website or blog:
In Part I of this three-part series, we focused on three mRNA technology market players: BioNTech, Moderna and CureVac. In this second post, we will focus on Translate BIO, Arcturus Therapeutics, and eTheRNA and discuss certain issues relating to lipid nanoparticle (LNP) delivery technology.
More mRNA Market Players
Translate Bio
Translate Bio, Inc. (NASDAQ: TBIO) is headquartered in Lexington, MA, and as of April 2021, has a market capitalization of over $1.3 billion.
According to its website, Translate BIO’s mRNA product pipeline is directed to several indications including cystic fibrosis, primary ciliary dyskinesia, pulmonary arterial hypertension, COVID-19, influenza, viral pathogens, and bacterial pathogens.
Dubai: The landscape of single-dose vaccines against COVID-19 just got more interesting. On Sunday, US health authorities approved the Janssen vaccine as a single-shot against COVID, with 78% efficacy. This is seen as a “game changer” in the global counter-coronavirus drive.
Data from the clinical trials and massive vaccination rollouts lead some experts to make a case for single shots from Pfizer and Moderna vaccines, too. The latter two are messenger RNA vaccines currently being rolled out in North America, Europe and the Middle East as a double dose.
With millions of doses per day being administered, there’s a decent amount of information for data scientists to crunch. Some experts argue this delayed or “fractional” dosing, could help the world achieve herd immunity sooner. Other scientists oppose the strategy. Here’s the lowdown on single-dose COVID shots: